Back to News
Market Impact: 0.45

Coveo Reports Second Quarter Fiscal 2027 Financial Results

Source: PR Newswire

Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsArtificial IntelligenceM&A & RestructuringCapital Returns (Dividends / Buybacks)
Coveo Reports Second Quarter Fiscal 2027 Financial Results

Coveo’s Q2 FY2027 revenue rose 8% year over year to US$40.4 million, including SaaS subscription revenue up 9% to US$39.1 million; adjusted EBITDA increased to US$2.0 million from US$0.6 million, while net loss narrowed to US$3.1 million from US$4.4 million. The company reported record quarterly new-business bookings, with generative AI solutions accounting for more than 50% of bookings, and announced its acquisition of Anglera. FY2027 guidance calls for US$156–158 million in SaaS subscription revenue, US$160–162 million in total revenue, and US$2–7 million in adjusted EBITDA; operating cash flow is expected to exceed US$10 million for the year. Coveo also repurchased 2,968,659 shares during the quarter, including a C$9.6 million buyback from a Qatar Investment Authority affiliate.

Analysis

The key debate is conversion quality, not whether enterprise AI interest exists. Bookings can lead revenue by several quarters, while a 102% net expansion rate implies limited cohort growth; the 105% figure excluding legacy Qubit attrition is the cleaner read, but still not evidence of broad-based expansion. Two large wins create upside to the pipeline narrative, yet customer concentration and implementation timing make bookings a weak near-term proxy for recurring revenue.

Earnings quality is the constraint on multiple expansion: positive adjusted EBITDA remains small relative to share-based compensation, and operating cash flow was negative as working capital absorbed cash. The full-year cash-flow target therefore depends on a material second-half reversal. The buyback reduces share count and removes one block of potential selling, but consumes liquidity alongside Anglera integration; acquisition economics and consideration are not disclosed, and the acquisition is excluded from outlook. Verify those terms before underwriting accretion.

Near term, the call and subsequent bookings-to-revenue conversion matter more than the record-bookings claim. Over 1–3 months, monitor Q3 delivery against guidance, cash conversion, and renewal/expansion metrics. Over 6–18 months, Coveo can benefit if enterprise commerce data enrichment becomes a differentiated layer for AI discovery; conversely, bundled offerings from Microsoft, Salesforce, and established search providers could cap pricing and make standalone deployments harder. Consensus may over-credit AI bookings while underweighting modest expansion and working-capital volatility. Falsifiers: SaaS revenue below guidance, deterioration in underlying retention/expansion, or failure to deliver the cash-flow recovery.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.45

Ticker Sentiment

CVO0.70

Key Decisions for Investors

  • Avoid chasing the bookings headline before management clarifies Anglera purchase terms and cash-flow seasonality on the call. Treat CVO as a conditional long, not a confirmed breakout.
  • For an event-driven entry, consider initiating a small CVO position on post-call weakness only if Q3 SaaS guidance remains intact and management supports the >$10 million full-year operating-cash-flow target with a credible working-capital bridge; no price target without valuation and market-price data.
  • Track reported net expansion alongside the Qubit-excluded measure, gross retention, and new-booking conversion over the next two quarters. Reduce or exit the thesis if underlying expansion reverses or SaaS revenue misses the guided range.
  • Do not yet pair CVO against larger platform vendors: the competitive risk is real, but the release provides no relative valuation, win-rate, or displacement data to support a risk-balanced short.

More News

From AllMind Research

Browse all research